Kindred Healthcare, Inc. (KND) Misses Q4 EPS by 9c; Cuts FY12 EPS Outlook
Tweet Send to a FriendGet Alerts KND Hot Sheet
Price: $14.00 +0.86%
Revenue Growth %: -1.9%
Financial Fact:
Gain (loss) on divestiture of operations: -1.24M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -1.9%
Financial Fact:
Gain (loss) on divestiture of operations: -1.24M
Today's EPS Names:
ANF, DXLG, FL, More
Trade KND Now!
Kindred Healthcare, Inc. (NYSE: KND) reported Q4 EPS of $0.27, $0.09 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.58 billion.
Kindred Healthcare, Inc. sees FY2012 EPS of $1.35-$1.55, versus prior guidance of $1.65-$1.85 and the consensus of $1.69. Kindred Healthcare, Inc. sees FY2012 revenue of $6.3 billion, versus the consensus of $6.4 billion.
For earnings history and earnings-related data on Kindred Healthcare, Inc. (KND) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Kindred Healthcare, Inc. sees FY2012 EPS of $1.35-$1.55, versus prior guidance of $1.65-$1.85 and the consensus of $1.69. Kindred Healthcare, Inc. sees FY2012 revenue of $6.3 billion, versus the consensus of $6.4 billion.
For earnings history and earnings-related data on Kindred Healthcare, Inc. (KND) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Nordson Corp (NDSN) Reports In-Line Q2 EPS, Q3 Guidance Falls Short
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

